{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:11:57Z","timestamp":1777349517022,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clim.2019.108321","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T05:47:23Z","timestamp":1575524843000},"page":"108321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Morbidity in an adenosine deaminase-deficient patient during 27\u00a0years of enzyme replacement therapy"],"prefix":"10.1016","volume":"211","author":[{"given":"Eyal","family":"Grunebaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Hershfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vy Hong-Diep","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Betschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim M.","family":"Roifman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0005","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2019.108321_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/srep40136","article-title":"Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients","volume":"7","author":"Sauer","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.clim.2019.108321_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00247-012-2564-2","article-title":"Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life","volume":"43","author":"Manson","year":"2013","journal-title":"Pediatr. Radiol."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0020","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jaci.2012.02.003","article-title":"Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency","volume":"129","author":"Grunebaum","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2019.108321_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10875-012-9658-3","article-title":"Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency","volume":"32","author":"Booth","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.108321_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-015-0365-z","article-title":"Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency","volume":"10","author":"Komarow","year":"2015","journal-title":"Orphanet J Rare Dis."},{"issue":"17","key":"10.1016\/j.clim.2019.108321_bb0035","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.clim.2019.108321_bb0040","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ymthe.2017.12.022","article-title":"Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety","volume":"26","author":"Cicalese","year":"2018","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.clim.2019.108321_bb0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1172\/JCI90367","article-title":"Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency","volume":"127","author":"Shaw","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.clim.2019.108321_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108321_bb0055","first-page":"349","article-title":"Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)","volume":"3","author":"Booth","year":"2009","journal-title":"Biologics."},{"issue":"3","key":"10.1016\/j.clim.2019.108321_bb0060","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2019.108321_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.12.009","article-title":"Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)","volume":"123","author":"Booth","year":"2007","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2019.108321_bb0070","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.1001770","article-title":"The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency","volume":"185","author":"Serana","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2019.108321_bb0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2013.12.1043","article-title":"B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients","volume":"133","author":"Brigida","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0080","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2011-07-366781","article-title":"Alterations in the adenosine metabolism and CD39\/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID","volume":"119","author":"Sauer","year":"2012","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-017-0421-7","article-title":"Long-term outcome of adenosine deaminase-deficient patients-a single-center experience","volume":"37","author":"Scott","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.108321_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","author":"Cagdas","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2019.108321_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2019.108321_bb0100","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/eji.200526248","article-title":"Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients","volume":"35","author":"Malacarne","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2019.108321_bb0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10875-015-0191-z","article-title":"Diagnosis, treatment and long-term follow up of patients with ADA deficiency: a single-center experience","volume":"35","author":"Baffelli","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2019.108321_bb0110","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2169","article-title":"A 24-year enzyme replacement therapy in an adenosine-deaminase-deficient patient","volume":"137","author":"Tartibi","year":"2016","journal-title":"Pediatrics."},{"key":"10.1016\/j.clim.2019.108321_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2019.108321_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpeds.2007.03.059","article-title":"Burkitt\u2019s lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase","volume":"151","author":"Husain","year":"2007","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.clim.2019.108321_bb0125","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/hmg\/4.11.2081","article-title":"Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA","volume":"4","author":"Santisteban","year":"1995","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 3","key":"10.1016\/j.clim.2019.108321_bb0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1469-1809.2006.00338.x","article-title":"Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry","volume":"71","author":"Sanchez","year":"2007","journal-title":"Ann. Hum. Genet."},{"issue":"18","key":"10.1016\/j.clim.2019.108321_bb0135","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.clim.2019.108321_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10875-017-0373-y","article-title":"How we manage adenosine deaminase-deficient severe combined immune deficiency (ADA SCID)","volume":"37","author":"Kohn","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2019.108321_bb0150","series-title":"GeneReviews\u00ae","first-page":"1993","author":"Hershfield","year":"2006"},{"key":"10.1016\/j.clim.2019.108321_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2018.06.011","article-title":"Hematological malignancies associated with primary immunodeficiency disorders","volume":"194","author":"Duan","year":"2018","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/02841860152619115","article-title":"The inherited basis of human radiosensitivity","volume":"40","author":"Gatti","year":"2001","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI4320","article-title":"Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination","volume":"103","author":"Gangi-Peterson","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.clim.2019.108321_bb0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","article-title":"Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency","volume":"129","author":"Kesserwan","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2019.108321_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.04.014","article-title":"Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency","volume":"127","author":"Grunebaum","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2019.108321_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/371370","article-title":"Mycobacterium genavense infections in a tertiary hospital and reviewed cases in non-HIV patients","author":"Santos","year":"2014","journal-title":"Pathol. Res. Int."},{"issue":"2","key":"10.1016\/j.clim.2019.108321_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2012.05.007","article-title":"Disseminated Mycobacterium genavense infection in a patient with a novel partial interleukin-12\/23 receptor \u03b21 deficiency","volume":"144","author":"Potjewijd","year":"2012","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2019.108321_bb0190","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood.V89.8.2849","article-title":"Adenosine deaminase deficiency in adults","volume":"89","author":"Ozsahin","year":"1997","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.clim.2019.108321_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01958426","article-title":"Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency","volume":"150","author":"Heyderman","year":"1991","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.clim.2019.108321_bb0200","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2009.07.003","article-title":"Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency","volume":"124","author":"Somech","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2019.108321_bb0205","article-title":"Chronic inflammatory demyelinating polyneuropathy in a patient with adenosine deaminase deficiency severe combined immunodeficiency: case report","volume":"2","author":"Shah","year":"2016","journal-title":"J Autoimmune Disord"},{"issue":"1","key":"10.1016\/j.clim.2019.108321_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-011-9593-8","article-title":"Primary immunodeficiency diseases associated with neurologic manifestations","volume":"32","author":"Dehkordy","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2019.108321_bb0215","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI115761","article-title":"IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency","volume":"89","author":"Chaffee","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"1 Suppl","key":"10.1016\/j.clim.2019.108321_bb0220","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1203\/00006450-199333011-00009","article-title":"Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy","volume":"33","author":"Hershfield","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clim.2019.108321_bb0225","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase (ADA) deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr. Opin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:59:08Z","timestamp":1761494348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619305352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S1521661619305352"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.108321","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbidity in an adenosine deaminase-deficient patient during 27\u00a0years of enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.108321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108321"}}